Wednesday, March 24, 2021 9:00:03 PM
“When do you expect FDA- approvals for either the intravenous or inhaled formulations?
We cannot speculate on the likelihood or timing of FDA approvals. Day 28 top-line results from the U.S. Phase 2b/3 trial with the IV formulation of RLF-100™ were announced in February 2021. We anticipate longer term day 60 data to follow in March...”
https://relieftherapeutics.com/investor-relations#
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM